Coronary atherosclerosis and cerebrovascular damage in a patient with systemi9c lupus erythematosus with antiphospholipid syndrome
Main Authors: | N V Seredavkina, T M Reshetnyak, D V Burenchev, L V Kondratyeva, E L Nasonov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA PRESS LLC
2008-06-01
|
Series: | Научно-практическая ревматология |
Online Access: | https://rsp.mediar-press.net/rsp/article/view/804 |
Similar Items
-
Aminoquinoline drugs in the treatment of systemic lupus erythematosus and antiphospholipid syndrome
by: L V Kondratyeva, et al.
Published: (2008-08-01) -
IgA Antiphospholipid Antibodies in Antiphospholipid Syndrome and Systemic Lupus Erythematosus
by: Tatiana Reshetnyak, et al.
Published: (2022-08-01) -
ACTOVEGIN IN THE COMPLEX THERAPY OF VASCULAR DISORDERS IN ANTIPHOSPHOLIPID SYNDROME
by: N V Seredavkina, et al.
Published: (2010-06-01) -
Systemic lupus erythematosus and antiphospholipid syndrome: past, present, future
by: Evgeny L. Nasonov, et al.
Published: (2023-07-01) -
Aspergillosis in systemic lupus erythematosus
by: T. M. Reshetnyak, et al.
Published: (2016-05-01)